Lifeward Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LFWD research report →
About the company
Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion.
- CEO
- William Mark Grant
- IPO
- 2014
- Employees
- 80
- HQ
- Yokneam Illit, IL
Price Chart
- Market Cap
- $12.92M
- P/E
- -0.41
- P/S
- 0.62
- P/B
- 2.05
- EV/EBITDA
- -0.61
- Div Yield
- 0.00%
- Gross Margin
- 36.55%
- Op Margin
- -120.25%
- Net Margin
- -123.66%
- ROE
- -243.14%
- ROIC
- -86.31%
- Revenue
- $22.03M · -14.14%
- Net Income
- $-19,914,000 · 31.19%
- EPS
- $-17.16 · 57.06%
- Op Income
- $-16,891,000
- FCF YoY
- 22.53%
- 52W High
- $10.98
- 52W Low
- $4.14
- 50D MA
- $7.09
- 200D MA
- $7.28
- Beta
- 0.37
- Avg Volume
- 9.16K
Get TickerSpark's AI analysis on LFWD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Rose Keith Dale | other | 15,000 |
| May 1, 26 | Rose Keith Dale | other | 0 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 0 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,006,113 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,666,666 |
| Mar 25, 26 | ORAMED PHARMACEUTICALS INC. | other | 1,666,666 |
| Mar 25, 26 | Sigsbee William Mark | other | 11,485 |
| Mar 25, 26 | Sigsbee William Mark | other | 0 |
| Mar 25, 26 | Rozenbaum Moshe H | other | 11,485 |
| Mar 25, 26 | Rozenbaum Moshe H | other | 0 |
Our LFWD coverage
Recent articles, reports, and earnings notes.
No research on LFWD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LFWD report →Similar companies
Peers in the same neighborhood.